Apellis Pharmaceuticals, Inc.
SEC Filing List
APLS CIK: 0001492422
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | O'brien Stephanie Monaghan | Apellis Pharmaceuticals, Inc. | 04/08/2026 | |
| SCHEDULE 13G/A | 04/07/2026 | ||||
| SC TO-C | Written communication relating to an iss... | Biogen Inc. | CRAVATH SWAINE & MOORE 01/FA | 04/07/2026 | |
| SCHEDULE 13D | CRAVATH SWAINE & MOORE 01/FA | 04/06/2026 | |||
| SC14D9C | Written communication by the subject com... | Apellis Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/06/2026 | |
| 3 | Initial statement of beneficial ownershi... | Biogen Inc. | CRAVATH SWAINE & MOORE 01/FA | 04/06/2026 | |
| SC TO-C | Written communication relating to an iss... | Biogen Inc. | CRAVATH SWAINE & MOORE 01/FA | 04/03/2026 | |
| SC TO-C | Written communication relating to an iss... | Biogen Inc. | CRAVATH SWAINE & MOORE 01/FA | 03/31/2026 | |
| SC14D9C | Written communication by the subject com... | Apellis Pharmaceuticals, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/31/2026 | |
| SC TO-C | Written communication relating to an iss... | Biogen Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/31/2026 | |
| No record found. | |||||
| Load More | |||||
